Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001088020-11-000065)

Filing Details

Accession Number:
0001088020-11-000065
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-09-09 13:20:31
Reporting Period:
2011-06-24
Filing Date:
2011-09-09
Accepted Time:
2011-09-09 13:20:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
892160 Derma Sciences Inc. DSCI Surgical & Medical Instruments & Apparatus (3841) 232328753
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1058190 F Bruce Wesson C/O Derma Sciences, Inc.
214 Carnegie Center, Suite 300
Princeton NJ 08540		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-09-06 10,000 $8.08 28,588 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock stock option (right to buy) Acquisiton 2011-06-24 5,000 $0.00 5,000 $10.26
Common Stock restricted stock units Acquisiton 2011-06-24 2,500 $0.00 2,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2012-05-26 2021-05-26 No 4 A Direct
2,500 2012-05-26 2012-05-26 No 4 A Direct
Footnotes
  1. This price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions reported on this line range from $8.05 to $8.09. The reporting person undertakes to provide Derma Sciences, Inc., any security holder of Derma Sciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  2. Includes 26,088 shares held in an IRA account.
  3. The options were issued in consideration of the reporting person's services to the issuer and without payment of cash consideration, under the issuer's stock option plan.
  4. Upon vesting, the reporting person will receive the number of shares of the issuer's common stock equal to the number of restricted stock units, without payment of further consideration.
  5. The restricted stock units were issued in consideration of the reporting person's services to the issuer and without payment of cash consideration, under the issuer's restricted stock plan.